CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
Biography
Dr. Mark Tyndall
Current Position
Program Director, Epidemiology, BC Centre for Excellence in HIV/AIDS
Director, Vancouver Injection Drug Users Study (VIDUS)
Primary Areas of Interest
Co-factors in HIV-1 transmission
Harm reduction interventions among injection drug users
Health care provision to marginalized populations
Social predictors of illness
Medical Training
McMaster University (1985)
Post-Graduate Training
Internal Medicine Fellowship, McMaster University (1989)
Fellowship in Infectious Diseases, University of Manitoba (1991)
Doctor of Science (ScD) - Epidemiology,
Harvard School of Public Health, USA (1998)
Associations
Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC)
Memberships
Canadian Infectious Diseases Society - CIDS
Physicians for Global Survival - PGS
American Society for Microbiology - ASM
Recent Publications
- Tyndall MW, Patrick D, Spittal P, Li K, O'Shaughnessy MV, Schechter MT, Risky sexual behaviours among injection drug users with high HIV prevalence: implications for STD control. Sex Trans Dis 2002, In press.
- Tyndall MW, Carib KJP, Currie S, Li K, O'Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users.
- J Acquir Immuno Def Synd 2001;28: 351-357. Patrick DM, Tyndall MW, Cornelisse PGA, Li K, Sherlock CH, Rekart ML, Stathdee SA, Currie SL, Schecter MT,
- O'Shaughnessy MV. The incidence of hepatitis C virus infection among injecting drug users during an outbreak of HIV infection. CMJA 2001;165:889-895.
List of presentations from this healthcare provider available on CMEonHIV :
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.